Integrity Applications
 

Integrity Applications is dedicated to the development and marketing of innovative needle free and pain free glucose monitoring

About Us
Integrity Applications is dedicated to the development and marketing of innovative needle free and pain free glucose monitoring
pressreleases

News & Press Releases

Articles & Reports from Integrity Applications

Integrity Applications Announces the Appointment of Allen E. Danzig to its Board of Directors and as Chair of the Nominating, Governance and Compensation Committee November 4th, 2019 Integrity Applications Announces the Appointment of Robert T. Guest as Senior Advisor May 16th, 2019 Integrity Applications Announces GlucoTrack® Customer Experience Program in the Netherlands December 17th, 2018
News & Press Articles
events

Events

Previous
Events

53rd EASD Annual Meeting 12 September 2017 American Diabetes Association’s 77th Scientific Sessions 09 June 2017 MEDinIsrael 2017 06 March 2017 ATTD 2017 Paris 16 February 2017
Events
investor relations

Investor Relations

Download reports and finance information

Investor Relations
Glucotrack User

Want to find out more about GlucoTrack?

Visit the GlucoTrack website

glucotrack.com

Sign up to our newsletter
To receive occasional news updates

LinkedIn Facebook Twitter

GlucoTrack® intended use: GlucoTrack® Model DF-F is a non-invasive intermittent glucose monitoring device for home-use. GlucoTrack® model DF-F is intended for adults 18 years and older with type 2 diabetes or pre-diabetes.

Medications intake and/or treatment decisions should not be based solely on GlucoTrack® model DF-F measurements. GlucoTrack® Model DF-F is a glucose monitoring device and should not be used for diagnosis purposes.

© 2019 Integrity Applications. All Rights Reserved.